Open AccessThe case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19
GlycobiologyPeer ReviewedRoger A. Laine2020Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support